Risk factors for progression from low level BK dnaemia to unfavorable outcomes after BK management via immunosuppressive reduction.
Abish KharelArjang DjamaliMargaret R JorgensonBeyann AlzoubiKurtis J SwansonNeetika GargFahad AzizMaha A MohamedDidier A MandelbrotSandesh ParajuliPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
Our study suggests that almost half of KTRs with BKPyV-DNAemia managed by our immunosuppressant adjustment protocol progress unfavorably. Identification of these risk factors could assist the frontline clinician in creating an individualized immunosuppressive modification plan potentially mitigating negative outcomes.